NMRA explores possibility of locally testing 160,000 Filgrastim injections rejected over labelling issue

Report Summary

The National Medicines Regulatory Authority (NMRA) is exploring the possibility of having a consignment of 160,000 Filgrastim injections tested locallyContinue Reading

Read full article on Newswire

Full article content remains on the original publisher's website.

Read Original Article